Avestar Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,745
| Closed | -$203K | – | 448 |
|
|
2024
Q4 | $203K | Buy |
+2,745
| New | +$203K | 0.02% | 449 |
|
|
2024
Q3 | – | Sell |
-2,943
| Closed | -$272K | – | 440 |
|
|
2024
Q2 | $272K | Buy |
2,943
+423
| +17% | +$39.1K | 0.03% | 323 |
|
|
2024
Q1 | $241K | Buy |
+2,520
| New | +$241K | 0.03% | 357 |
|
|
2019
Q3 | – | Sell |
-84
| Closed | -$4K | – | 389 |
|
|
2019
Q2 | $4K | Hold |
84
| – | – | ﹤0.01% | 603 |
|
|
2019
Q1 | $4K | Hold |
84
| – | – | ﹤0.01% | 588 |
|
|
2018
Q4 | $2K | Hold |
84
| – | – | ﹤0.01% | 624 |
|
|
2018
Q3 | $4K | Buy |
84
+9
| +12% | +$429 | ﹤0.01% | 569 |
|
|
2018
Q2 | $1K | Buy |
75
+12
| +19% | +$160 | ﹤0.01% | 755 |
|
|
2018
Q1 | $1K | Buy |
63
+45
| +250% | +$714 | ﹤0.01% | 711 |
|
|
2017
Q4 | $0 | Buy |
+18
| New | – | ﹤0.01% | 759 |
|